The robust response of LLC-GCSF tumor-bearing mice resulted in a greater decrease in tumor volume following one week of treatment with both α-PD-L1 (p < 0.01, Figure 1D) and α-PD-1 (p < 0.001, Figure 1E), compared to LLC tumor-bearing mice. Here, CD274 is linked to neoplasm.